Clinical trial · Interventional
Short Term Effects of Photodynamic Therapy in Basal Cell Carcinoma
NCT01015898CI-TRIAL-00002781completedPhase 1ClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to evaluate the efficacy of photodynamic therapy in treatment of Basal cell carcinoma (BCC) and factors that affect response rate.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Basal Cell Carcinoma | Basal Cell Carcinoma | ONTOLOGY_EXACT | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| photodynamic therapy | Radiation | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- type
- EXPERIMENTAL
- label
- BCC, ALA-PDT
- description
- Patients with histologically proven basal cell carcinoma who were candidates for treatment with ALA-PDT
- interventionNames
- Radiation: photodynamic therapy
Primary outcomes (0)
[]Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria: * Histologically proven BCCs Exclusion Criteria: * Rodent ulcer * Morphea type * ANA + * History of photosensitivity or photodermatosis or ingestion of phototoxic * Drugs during last month * Pregnancy * Breast feeding * Age\< 18 * History of another therapeutic intervention for bcc during last 6 months
References
Publications (0)
Data not yet available
No reference posted for this study.